Cargando…
VivaGel(™) (SPL7013 Gel): A candidate dendrimer – microbicide for the prevention of HIV and HSV infection
Microbicides are compounds that applied vaginally or rectally, protect the user from sexually transmitted infections. Although no commercial product is yet available, many candidates are under development. A leading candidate, VivaGel(™) (SPL7013 Gel) is the product of nanotechnology. The active ing...
Autores principales: | Rupp, Richard, Rosenthal, Susan L, Stanberry, Lawrence R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676817/ https://www.ncbi.nlm.nih.gov/pubmed/18203424 |
Ejemplares similares
-
SPL7013 Gel (VivaGel®) Retains Potent HIV-1 and HSV-2 Inhibitory Activity following Vaginal Administration in Humans
por: Price, Clare F., et al.
Publicado: (2011) -
A Phase I Randomized Placebo Controlled Trial of the Safety of 3% SPL7013 Gel (VivaGel®) in Healthy Young Women Administered Twice Daily for 14 Days
por: Cohen, Craig R., et al.
Publicado: (2011) -
HSV Neutralization by the Microbicidal Candidate C5A
por: de Witte, Lot, et al.
Publicado: (2011) -
Efficacy, Stability, and Biosafety of Sifuvirtide Gel as a Microbicide Candidate against HIV-1
por: Li, Liangzhu, et al.
Publicado: (2012) -
Measuring Dilution of Microbicide Gels with Optical Imaging
por: Drake, Tyler K., et al.
Publicado: (2013)